SUBSCRIBE
SUBSCRIBE
News   Policy

CBER: Supplement Approval: Influenza Virus Vaccine (FluLaval)

July 28, 2008 | 
1 min read

Product Approval Information - Licensing Action

Regulatory
MORE ON THIS TOPIC
Light at the end of railroad tunnel. Natural lighting.
FDA
UniQure snags May Day decision date for Huntington’s gene therapy after arduous year
November 2, 2026
 · 
2 min read
 · 
Heather McKenzie
Wind up Earth globe green-blue pastel color on pink background. Designed in minimal concept. 3D Render.
Drug Development
Can Saudi Arabia’s burgeoning biotech hub withstand geopolitical pressures?
November 2, 2026
 · 
6 min read
 · 
Jennifer C. Smith-Parker
Insights
Stability, speed and strategy: Inside Australia’s early‑stage edge
October 29, 2026
 · 
1 min read
 · 
Jennifer C. Smith-Parker
Staying ahead of your competitors. Accelerated development of the company. Innovation vision. Customized solution. Unique skills. Red paper plane and whites. 3d render
FDA
New FDA draft guidance doubles down on expediting approvals of personalized gene therapies
October 28, 2026
 · 
4 min read
 · 
Heather McKenzie